Pierre Comby

670 total citations
12 papers, 525 citations indexed

About

Pierre Comby is a scholar working on Oncology, Pharmacology and Pharmacology. According to data from OpenAlex, Pierre Comby has authored 12 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Pharmacology and 4 papers in Pharmacology. Recurrent topics in Pierre Comby's work include Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Hormonal and reproductive studies (2 papers). Pierre Comby is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Hormonal and reproductive studies (2 papers). Pierre Comby collaborates with scholars based in France, United Kingdom and United States. Pierre Comby's co-authors include Don K. Walker, Dennis A. Smith, Angus N. R. Nedderman, S. J. Roffey, S. G. Jezequel, Nolan Wood, Soren Cole, Sylvie Abel, Gary J. Muirhead and Claude Charuel and has published in prestigious journals such as Drug Metabolism and Disposition, Toxicology Letters and Regulatory Toxicology and Pharmacology.

In The Last Decade

Pierre Comby

12 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Comby France 9 292 119 87 84 75 12 525
Albert Dorr United States 15 194 0.7× 348 2.9× 86 1.0× 122 1.5× 33 0.4× 27 783
Annie Fang United States 13 155 0.5× 117 1.0× 64 0.7× 45 0.5× 30 0.4× 29 394
SH Khoo United Kingdom 15 614 2.1× 200 1.7× 40 0.5× 275 3.3× 77 1.0× 40 843
Donald P. Zarowny Canada 8 189 0.6× 233 2.0× 65 0.7× 34 0.4× 19 0.3× 8 410
Chiara Carcieri Italy 11 210 0.7× 131 1.1× 103 1.2× 36 0.4× 39 0.5× 20 443
Lena Ekman Sweden 11 85 0.3× 46 0.4× 92 1.1× 12 0.1× 78 1.0× 16 617
Richard M. Hoglund Thailand 13 211 0.7× 51 0.4× 57 0.7× 8 0.1× 67 0.9× 30 510
S. Pukrittayakamee Thailand 22 89 0.3× 160 1.3× 47 0.5× 15 0.2× 235 3.1× 37 1.2k
Jennifer Lynn Ford United States 19 330 1.1× 177 1.5× 31 0.4× 213 2.5× 33 0.4× 47 1.1k
L. Pou Spain 15 251 0.9× 248 2.1× 104 1.2× 17 0.2× 9 0.1× 26 521

Countries citing papers authored by Pierre Comby

Since Specialization
Citations

This map shows the geographic impact of Pierre Comby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Comby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Comby more than expected).

Fields of papers citing papers by Pierre Comby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Comby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Comby. The network helps show where Pierre Comby may publish in the future.

Co-authorship network of co-authors of Pierre Comby

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Comby. A scholar is included among the top collaborators of Pierre Comby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Comby. Pierre Comby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Osman‐Ponchet, Hanan, et al.. (2016). Lack of effect of selected sunscreens applied on ex vivo human skin for 5-methyl-aminolevulinic acid penetration and protoporphyrin IX photoactivation. Photodiagnosis and Photodynamic Therapy. 17. 75–81. 4 indexed citations
2.
Dion, Sarah, et al.. (2015). Oral toxicity of Miglyol 812® in the Göttingen® minipig. Regulatory Toxicology and Pharmacology. 73(3). 930–937. 12 indexed citations
3.
Comby, Pierre, et al.. (2015). Characterization of SLC transporters in human skin. ADMET & DMPK. 3(1). 6 indexed citations
4.
Osman‐Ponchet, Hanan, et al.. (2014). Characterization of ABC transporters in human skin. Drug metabolism and drug interactions. 29(2). 91–100. 28 indexed citations
5.
Hanton, G., et al.. (2008). Characterisation of the vascular and inflammatory lesions induced by the PDE4 inhibitor CI-1044 in the dog. Toxicology Letters. 179(1). 15–22. 11 indexed citations
6.
Walker, Don K., Sylvie Abel, Pierre Comby, et al.. (2005). SPECIES DIFFERENCES IN THE DISPOSITION OF THE CCR5 ANTAGONIST, UK-427,857, A NEW POTENTIAL TREATMENT FOR HIV. Drug Metabolism and Disposition. 33(4). 587–595. 122 indexed citations
7.
Abbott, D. P., Pierre Comby, Claude Charuel, et al.. (2004). Preclinical safety profile of sildenafil. International Journal of Impotence Research. 16(6). 498–504. 46 indexed citations
9.
Roffey, S. J., Soren Cole, Pierre Comby, et al.. (2003). THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN. Drug Metabolism and Disposition. 31(6). 731–741. 258 indexed citations
10.
Walker, Don K., et al.. (2001). Pharmacokinetics and metabolism of a selective PDE5 inhibitor (UK-343,664) in rat and dog. Xenobiotica. 31(8-9). 651–664. 8 indexed citations
11.
Amacher, David E., et al.. (1998). In vitro toxicity of zamifenacin (UK-76,654) and metabolites in primary hepatocyte cultures. Xenobiotica. 28(9). 895–908. 8 indexed citations
12.
Charuel, Claude, Pierre Comby, & A. M. Monro. (1992). Diurnal exposure profile in rats from dietary administration of a chemical (doxazosin) with a short half‐life: Interplay of age and diurnal feeding pattern. Journal of Applied Toxicology. 12(1). 7–11. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026